Revenue - Standard Chem & Pharm Co Ltd (TWSE:1720) - Alpha Spread

Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 65.1 TWD 0.46% Market Closed
Market Cap: 11.6B TWD
Have any thoughts about
Standard Chem & Pharm Co Ltd?
Write Note

Standard Chem & Pharm Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Standard Chem & Pharm Co Ltd
Revenue Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1795

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Standard Chem & Pharm Co Ltd
TWSE:1720
Revenue
NT$6.6B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
8%
Y
YungShin Global Holding Corp
TWSE:3705
Revenue
NT$7.4B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Formosa Laboratories Inc
TWSE:4746
Revenue
NT$4.7B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
5%
ScinoPharm Taiwan Ltd
TWSE:1789
Revenue
NT$3.4B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
-3%
S
SCI Pharmtech Inc
TWSE:4119
Revenue
NT$1.3B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Revenue
NT$16.9B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
23%

See Also

What is Standard Chem & Pharm Co Ltd's Revenue?
Revenue
6.6B TWD

Based on the financial report for Jun 30, 2024, Standard Chem & Pharm Co Ltd's Revenue amounts to 6.6B TWD.

What is Standard Chem & Pharm Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
8%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Standard Chem & Pharm Co Ltd have been 14% over the past three years , 12% over the past five years , and 8% over the past ten years .

Back to Top